Fintel reports that on October 25, 2024, Citigroup downgraded their outlook for Bristol-Myers Squibb (NYSE:BMY) from Buy to ...

Expectations for Bristol Myers Squibb's Q3 results have significantly declined. Despite this, check out why I maintain a "Buy ...

Global Trust Asset Management LLC cut its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 20.0% in the third ...

Equities researchers at Leerink Partnrs decreased their Q3 2024 EPS estimates for Bristol-Myers Squibb in a research report ...

Key scientific achievements drive the expansion of the pipeline of molecular glue degraders in fields beyond oncology Evotec ...

Evotec announced in May of 2022 that the Company has further extended and expanded its partnership with Bristol Myers Squibb for another 8 years as the initial collaboration proved to be highly ...

Fintel reports that on October 17, 2024, Bernstein initiated coverage of Bristol-Myers Squibb (NYSE:BMY) with a Market ...

Key Insights Significantly high institutional ownership implies Bristol-Myers Squibb's stock price is sensitive ...

Shares of Bristol Myers Squibb Co. BMY advanced 1.23% to $52.76 Tuesday, on what proved to be an all-around poor trading ...

Bristol-Myers Squibb (BMY – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst David Risinger from Leerink Partners maintained a Hold rating on ...

The Bristol Myers Squibb Foundation, an independent charitable organization, has awarded Baylor College of Medicine Global Health $2.25 million for ...

We recently compiled a list of the Jim Cramer’s Exclusive List of 9 YEV Stocks. In this article, we are going to take a look ...